Pathophysiology of the vascular wall: The role of nitric oxide in renal disease

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 1, 1996, Pages 53-58

  Raij, L ^a   Jaimes, E ^a   Del Castillo, D ^a   Guerra, J ^a   Westberg, G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTERY TONE; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; ISCHEMIA; KIDNEY DISEASE; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029878686     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90081-2     Document Type: Conference Paper

References (83)

1. Palmer R M J, Ashton D S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
2. Ignarro L J, Lippton H, Edwards J C et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide; evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
3. Furchgott R F. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P M, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press, 1988: 401-414.
4. Gryglewski RJ, Palmer R M J, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-456.
5. Beckman J S, Beckman T W, Chen J, Marshall P A, Freeman B A. Apparent hydroxyl radical production by peroxynitrite: implications for the endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
6. Vane J R, Anggard E E, Botting R M. Regulatory functions of the vascular endothelium. New Engl J Med 1990; 323: 26-27
7. Vanhoutte P M, Rubany G M, Miller V M, Houston D S. Modulation of vascular smooth muscle contraction by endothelium. Annu Rev Physiol 1986; 48: 307-320.
8. Shultz P, Tolins J P, Raij L Endothelial-derived vasoactive substances and the kidney. Kidney 1990; 23(3): 1-8.
9. Sweeney C, Shultz P, Raij L. Interactions of the endothelium and mesangium in glomerular injury. J Am Soc Nephrol 1990; 1: S13-S20.
10. Michael A F, Keane W F, Raij L, Vernier R L, Mauer S M. The glomerular mesangium. Kidney Int 1980; 17: 141-154.
11. Latta H, Maunschbach A B, Madden S C. The centralobular region of the renal glomerulus studied by electron microscopy. J Ultrastruct Res 1960; 4: 455-472.
12. Raij L, Keane W F. Glomerular mesangium: Its function and relationship to angiotensin II. Am J Med 1985; 79 (suppl 36): 24-30.
13. Schlondorff D. The glomerular mesangial cell: An expanding role for specialized preicyte. FASEB J 1987; 1: 272-281.
14. Mene P, Simonson M S, Dunn M J. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-1424.
15. Shultz P J, Shorer A E, Raij L. Effects of endothelium derived relaxing factor and nitric oxide in rat mesangial cells. Am J Physiol 1990; 258: F162-F167.
16. Radomski M W, Palmer R M J, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
17. Tolins J P, Palmer R M J, Moncada S, Raij L: Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990; 258: H655-H662.
18. Rees D D, Palmer R M J, Moncada S. The role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 3375-3378.
19. Vidal-Ragout M, Romero J C, Vanhoutte P M. Endothelium-derived relaxing factor inhibits rennin release. Eur J Pharmacol 1988; 149: 401-402.
20. Wilcox C S, Welch W J, Tojo A, Tisher C C, Schmidt H H W: A constitutive nitric oxide synthase localizes to macula densa and mediates a salt-sensitive vasodilator component of tubuloglomerular feedback (abstract). JASN 1992; 3: 556.
21. Tolins J P, Raij L. Effects of amino acid infusion on renal hemodynamics: role of endothelium-derived relaxing factor. Hypertension 1991; 17: 1045-1051.
22. Ito S, Johnson C S, Carretero O A. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991; 187: 1656-1663.
23. De Nicola L, Blantz R C, Gabbai F B. Nitric oxide and angiotensin II glomerular and tubular interaction in the rat. J Clin Invest 1992; 89: 1248-1256.
24. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281.
25. King A J, Brenner B M, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: 1051-1058.
26. Grag U C, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989; 257: F60-F66.
27. Shultz P, Ruble D, Raij L S-Nitroso-n-acetylpenicillamine (SNAP) inhibits mitogen-induced mesangial cell proliferation. Kidney Int 1990; 37: 203 (abstr).
28. Raij L. Nitric oxide and the kidney. Circulation 1993; 87: V26-V29.
29. Beierwaltes W H, Carretero O A. Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 1992; 19: 68-73.
30. Sigmon D H, Carretero O A, Beierwaues W H. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 263: F256-F261.
31. Salazar F J, Pinilla J M, Lopez F, Romero J C, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 1992; 20: 113-117.
32. Shultz P J, Tolins J P. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest 1993; 91: 642-650.
33. Salazar F J, Alberola A, Pinilla J M, Romero J C, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993; 22: 49-55.
34. Conger J D, Robinette J B, Schrier R W. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988; 82: 532-537
35. Firth J D, Ratcliffe P J. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 1992; 90: 1023-1031.
36. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989; 83: 1762-1767.
37. Henrich W L, McAllister E A, Smith P B, Campbell W B. Guanosine 3′, 5′-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol 1988; 255: F474-F478.
38. Romero J C, Lahera V, Salom M G, Biondi M L. Role of endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 1992; 2: 1371-1387.
39. Stoos B A, Carretero O A, Farhy R D, Scicli G, Garvin J L. Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells. J Clin Invest 1992; 89: 761-765.
40. Chen P Y, Sanders P W. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88: 1559-1567.
41. Moncada S, Palmer R M J, Higgs E A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-141.
42. Radomski M W, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993; 27: 1380-1382.
43. Wilson C B. The renal response to immunologic injury. In: Brenner and Rector, eds. The kidney. 4th ed. Philadelphia: W. B Saunders, 1991: vol 1, chap 25, 1062-1181.
44. Raij L. Glomerular thrombosis in pregnancy: role of L-arginine and nitric oxide pathway. Kidney Int 1994; 45: 775-781.
45. Bone R C. The pathogenesis of sepsis. Ann Int Med 1991; 115: 457-469.
46. Hibbs J B Jr, Taintor R R, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235: 473-476.
47. Iyengar R, Stuehr D J, Marietta M A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci 1987; 84: 6369-6373.
48. Xie Q-W, Cho H J, Calaycay J et al.Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-228.
49. Pollock J S, Forstermann U, Mitchell J A et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88: 10480-10484.
50. Bredt S, Hwang P M, Glatt C E, Lowenstein D, Reed R R, Snyder S H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase. Nature 1991; 351: 714-718.
51. Bredt D S, Ferris C D, Snyder S H. Nitric oxide synthase regulatory sites. J Biol Chem 1992; 267: 10976-10981.
52. Lamas S, Marsden P A, Li G K, Tempst P, Michel T L. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348-6352.
53. Lyons C R, Orloff G J, Cunningham J M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992; 267: 6370-6374.
54. Shultz P J, Tayeh M A, Marletta M A, Raij L. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 1991; 261: F600-F606.
55. Marsden P A, Ballermann B J. Tumor necrosis factor o activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 1990; 172: 1842-1852.
56. Pfeilschifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R. Interleukin 113 and tumour necrosis factor induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 1992; 203: 251-255.
57. Shultz P J, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
58. Giroir B P, Johnson J H, Brown T, Allen G L, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992; 90: 693-698.
59. Van Der Poll T, Buller H R, Ten Cate H et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-1627.
60. Durantc W, Schini V B, Catovsky S, Kroll M H, Vanhoutte P M, Schafer A L. Plasmin potentiates induction of nitric oxide synthesis by interleukin-113 in vascular smooth muscle cells. Am J Physiol 1993; 264: H617-H624.
61. Schini V B, Catovski S, Durante W, Scott-Burden T I, Schafer A L, Vanhoutte P M. Thrombin inhibits induction of nitric oxide synthase in cultured vascular smooth muscle cells. Am J Physiol (Heart Circ Physiol 33) 1993; 264: H611-H616.
62. Lindheimer M D, Katz A L. Renal physiology and disease in pregnancy. In: Seldin D W, Giebisch G (eds). The kidney; physiology and pathophysiology. New York: Raven Press, 1992; 3371-3432.
63. Bergstein J M, Hoyer J R, Michael A F Jr. Glomerular dynamics and morphologic changes in the generalized Schwartzman reaction in postpartum rats. J Clin Invest 1981; 67: 1334-1344.
64. Roberts J M, Taylor R N, Musci T J, Rogers G M, Hubel C A, Mclaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
65. Kilbourn R G, Gross S S, Jubran A et al. N9-Methyl-L-arginine hibits tumor necrosis factor induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629-3632.
66. Nathan C F, Stuehr D J. Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension? J Natl Cancer Inst 1990; 82: 762-772.
67. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
68. Fleming I, Gray G A, Julou-Schaeffer G, Parratt J R, Stoclet J-C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 1990; 171: 562-568.
69. Beasley D, Schwartz J H, Brener B M. Interleukin 1 induces prolonged L-arginine dependent cyclic guanosine monophosphate in nitric production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602-608.
70. Cook H T, Sullivan R. Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am J Phatol 1991; 139: 1047-1052.
71. Cattell V, Largen P, De Heer E, Cook T. Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. Kidney Int 1991; 40: 847-851.
72. Cattell V, Lianos E, Largen P, Cook T. Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1993; 1: 36-40.
73. Baud L, Oudinet J-P, Bens M et al. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipoplysaccharide. Kidney Int 1989; 35: 1111-1118.
74. Busse R, Mulsch A L. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 277: 87-90.
75. Schlondorff D. The glomerular mesangial cell: An expanding role for specialized parasite. FASEB J 1987; 1: 272-281.
76. 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 1990; 145: 940-944.
77. 2 inhibits interleukin 1β and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 1991; 175: 372-379.
78. Oswald I P, Gazzinelli R T, Sher A, James S L: IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578-3582.
79. Jansen A, Lewis S, Cattell V, Cook H T. Arginase is a major pathway of L arginine metabolism in nephritic glomeruli. Kidney Int 1992; 42: 1107-1112.
80. Stamler J S, Singel D J, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258: 1898-1902.
81. Beckman J S, Beckman T W, Chen J, Marshall P A, Freeman B A: Apparent hydroxyl radical production by peroxynitrite: implications for the endothelial injury from nitric oxide and superoxide. Proc Natl Acad, Sci USA 1990; 87: 1620-1624.
82. Shah, S V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093-1106.
83. Lipton S A, Choi Y-B, Pan Z-H et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 1993; 364: 626-631.